产品详情
所在位置: 首页> 产品目录> 二抗>
查看大图

  • 产品名称：Rabbitanti-HumanIgG(Heavy&LightChain)Antibody(TexasRed(TR))

  • 产品型号：
  • 产品厂商：BioLeaf
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
Rabbitanti-HumanIgG(Heavy&LightChain)Antibody(TexasRed(TR))
详情介绍：
Immunogen Human IgG whole molecule
Isotype IgG
Specificity IgG (H&L)
Characteristics Concentration Definition: by UV absorbance at 280 nm
Purification This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption (s) to remove any unwanted reactivities. Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Rabbit Serum, Human IgG and Human Serum.
Research Area Immunology, Secondary Antibodies
Application Notes This product is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.
Comment

Texas Red™ is a registered trademark of Molecular Probes Inc.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Restore with deionized water (or equivalent)
Concentration 2.0 mg/mL
Buffer 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Handling Advice Product is photosensitive and should be protected from light.
Product cited in: Zschüntzsch, Zhang, Klinker, Makosch, Klinge, Malzahn, Brinkmeier, Liebetanz, Schmidt: "Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy." in: Journal of neurochemistry, Vol. 136, Issue 2, pp. 351-62, 2016 (PubMed).

Zschüntzsch, Voss, Creus, Sehmisch, Raju, Dalakas, Schmidt: "Provision of an explanation for the inefficacy of immunotherapy in sIBM: Quantitative assessment of inflammation and β-amyloid in the muscle." in: Arthritis and rheumatism, 2012 (PubMed).